Area of research
Epidemiology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Alcohol Consumption and Health Effects, Diabetes, Cardiovascular Risks, and Lipoproteins, and Adipokines, Inflammation, and Metabolic Diseases.
Intratumoral delivery of PD-1/PD-L1 and CTLA-4 inhibitors for recurrent/refractory solid tumors: a proof-of-concept treatment strategy
Dietary Niacin Intake and Mortality Among Individuals With Nonalcoholic Fatty Liver Disease
Association between Dietary Niacin Intake and Nonalcoholic Fatty Liver Disease: NHANES 2003–2018
Effective sequential combined therapy with carboplatin and a CDC7 inhibitor in ovarian cancer
IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin
CBD Alleviates Liver Injuries in Alcoholics With High-Fat High-Cholesterol Diet Through Regulating NLRP3 Inflammasome–Pyroptosis Pathway
Cyanidin-3-O-β-glucoside inactivates NLRP3 inflammasome and alleviates alcoholic steatohepatitis via SirT1/NF-κB signaling pathway
Anthocyanins regulate serum adipsin and visfatin in patients with prediabetes or newly diagnosed diabetes: a randomized controlled trial
Novel anilino quinazoline-based EGFR tyrosine kinase inhibitors for treatment of non-small cell lung cancer
Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high‐fat high cholesterol diet via regulating NF‐κB and NLRP3 inflammasome pathway
Role of Purified Anthocyanins in Improving Cardiometabolic Risk Factors in Chinese Men and Women with Prediabetes or Early Untreated Diabetes—A Randomized Controlled Trial
<scp>AMP</scp>‐activated protein kinase regulates lipid metabolism and the fibrotic phenotype of hepatic stellate cells through inhibition of autophagy
Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy